发明名称 |
Glial cell line-derived neurotrophic factor (GDNF) compositions and use thereof |
摘要 |
Described herein is the identification of primate-specific glial cell line-derived neurotrophic factor opposite strand (GDNFOS) transcripts and encoded peptides. In particular embodiments, provided herein are three GDNFOS antisense transcripts, referred to as GDNFOS-1, GDNFOS-2 and GDNFOS-3. The GDNFOS-3 transcript encodes an ORF of 105 amino acids. Compositions comprising the GDNFOS transcripts and peptides are also provided by the present disclosure. Further provided are methods of treating a neurodegenerative or peripheral organ disease in a subject by administering a therapeutically effective amount of the disclosed GDNFOS nucleic acid molecules, peptides or compositions. |
申请公布号 |
US8999927(B2) |
申请公布日期 |
2015.04.07 |
申请号 |
US201313855533 |
申请日期 |
2013.04.02 |
申请人 |
The United States of America, as represented by the Secretary, Department of Health and Human Services |
发明人 |
Liu Qing-Rong |
分类号 |
C07K14/47;C07K14/475;C07K16/22 |
主分类号 |
C07K14/47 |
代理机构 |
Klarquist Sparkman, LLP |
代理人 |
Klarquist Sparkman, LLP |
主权项 |
1. A fusion protein comprising a glial cell line-derived neurotrophic factor opposite strand (GDNFOS) peptide and a heterologous protein, wherein the GDNFOS peptide comprises an amino acid sequence at least 90% identical to SEQ ID NO: 4 or at least 90% identical to residues 29-105 of SEQ ID NO: 4. |
地址 |
Washington DC US |